Webinar On ADHD: Diagnosis and Subtyping

  • Check with publisher
  • Published date: April 6, 2018
    • Fremont, California, United States

Overview: In this program Dr. Barkley provides detailed information on the specific

nature of ADHD symptoms as revealed by clinical research so as to better inform the current

diagnostic criteria for ADHD. He then reviews the various modifications necessary for updating

the DSM criteria and making them more useful with special populations (girls, adults, etc.).

He also addresses the changes that are still needed to improve these diagnostic criteria based

on findings in the research literature. Dr. Barkley then addresses the issue of subtyping of

ADHD along with the emerging conclusion that one form of the inattentive type may constitute a

new disorder known in research as sluggish cognitive tempo or sometimes called ADD by

clinicians.

Why should you Attend: Attendance will familiarize you with the latest criteria for diagnosing

ADHD in children and adults including not just the DSM-5 criteria, but also the modifications

that are essential for applying those diagnostic criteria to special populations (girls,

adults, etc.). These modifications were well documented in research over the past decade yet

went ignored in the final version of DSM-5. You will find that clinicians can not afford to

ignore such evidenced-based adjustments that permit a more rigorous approach to the diagnosis

of ADHD than that permitted in the DSM-5 criteria.

These criteria will also be further informed by the latest clinical research perspective on the

nature of ADHD as a disorder of executive functioning and self-regulation. The clinical

implications of this perspective are far more useful for understanding the management of ADHD

than is the attention deficit perspective.

Furthermore, those attending will learn about the new disorder of attention known as sluggish

cognitive tempo that has come to replace the earlier Inattentive Type of ADHD, a subtype no

longer recognized in DSM-5 as it has been demoted to a presentation. You won’t want to miss out

on these cutting edge discoveries and their clinical implications as presented by an

international authority on ADHD who tracks the published research findings weekly and brings

those findings into his presentations.
Price - $139
Contact Info:
Netzealous LLC - MentorHealth
Phone No: 1-800-385-1607
Fax: 302-288-6884
Email: support@mentorhealth.com
Website: http://www.mentorhealth.com/
Webinar Sponsorship: https://www.mentorhealth.com/control/webinar-sponsorship/
http://www.mentorhealth.com/control/w_product/~product_id=801267LIVE?science-marketplace.org_may_2018_SEO

Result 0 votes
Roger Steven
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Scoop - Top Targets of Fed HIPAA Enforcers & Simple Steps to Take Control

    Scoop - Top Targets of Fed HIPAA Enforcers & Simple Steps to Take Control

    Medical Sciences Fremont (California) April 6, 2018 Check with publisher

    Overview: This webinar for HIPAA Covered Entities and Business Associates will identify the top OCR HIPAA enforcement priorities for 2018 and explain simply how you can master HIPAA compliance requirements for each enforcement priority. Why should yo...

  • Validation for the New FDA Inspections

    Validation for the New FDA Inspections

    Medical Sciences Fremont (California) February 22, 2018 Check with publisher

    Overview: How to conduct a software validation program that will satisfy FDA requirements and produce a safe product. Why should you Attend: There are additional requirements,analyses and tests that FDA feels are necessary to prevent user injuries. T...

  • Discussion on Raw Material Methods and Specifications

    Discussion on Raw Material Methods and Specifications

    Medical Sciences Fremont (California) February 22, 2018 Check with publisher

    Overview: Based on knowledge of the active and inactive ingredient's function and role in the finished dosage form, Compendia methods and specifications are clearly accepted by third parties and regulatory agencies. Why should you Attend: The FDA has...